Physician profile
John Roland
NPI 1962445411
$85,982.21
in general payments reported to CMS, 2019-2025
14 companies · $15K in 2025
The $15K reported for 2025 was more than what 92% of Otology & Neurotology providers received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $70.01 · 2021: $16K · 2022: $9,441 · 2023: $9,698 · 2024: $8,536 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $11K · Food and Beverage: $2,767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $19,400.00 |
| Travel and Lodging | $10,918.33 |
| Food and Beverage | $2,767.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $51,924.90 | 2019-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Cochlear Ag | $11,887.83 | 2019-2020 | |
| Eli Lilly and Company | $9,000.00 | 2024-2025 | |
| Iotamotion, INC. | $8,465.35 | 2022-2025 | Iotasoft Insertion System, Iotasoft |
| Cochlear Ltd | $4,190.08 | 2019 | |
| Oticon Medical, LLC | $172.58 | 2021 | |
| Grace Medical, INC. | $152.48 | 2019 | |
| Medtronic, INC. | $91.00 | 2025 | Nim Vital |
| Integra Lifesciences Corporation | $36.21 | 2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Novartis Pharmaceuticals Corporation | $17.74 | 2019 | |
| Jazz Pharmaceuticals INC. | $16.21 | 2022 | |
| Nobelpharma America, LLC | $14.00 | 2023 | |
| Optinose US, INC. | $13.83 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Roland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.